Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Cancer Cells

[Image: see text] Platinum(IV) anticancer agents have demonstrated the potential to overcome the limitations associated with the widely used Pt(II) chemotherapeutics, cisplatin, carboplatin, and oxaliplatin. In order to identify therapeutic scenarios where this type of chemotherapy can be applied, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulet, Marie H. C., Bolland, Hannah R., Hammond, Ester M., Sedgwick, Adam C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288503/
https://www.ncbi.nlm.nih.gov/pubmed/37283248
http://dx.doi.org/10.1021/jacs.3c03320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288503/
https://www.ncbi.nlm.nih.gov/pubmed/37283248
http://dx.doi.org/10.1021/jacs.3c03320

Ejemplares similares